The study revealed a significant increase in ETO-induced cell death upon downregulation of UBE2S expression, indicating that UBE2S downregulation heightened the sensitivity of gliomas to ETO in vivo. The gene discussed is RUNX1T1; the disease is central nervous system cancer.